What This Document Is
This document is a review resource for Chamberlain University’s NR 324 Adult Health I Second Exam. It consolidates key information from Chapters 29 and 30, focusing on hematologic assessment and common hematologic problems. It’s designed to help students prepare for an exam covering these topics.
Why This Document Matters
This review is valuable for nursing students preparing to assess and understand patients with blood-related disorders. It’s most useful during exam preparation, as a quick reference for common conditions, and for understanding key laboratory values. It exists to help students synthesize information from textbook chapters into a more manageable format.
Common Limitations or Challenges
This review is *not* a substitute for reading the assigned textbook chapters or attending lectures. It provides a condensed overview and does not include in-depth explanations of pathophysiology or detailed treatment protocols. It also doesn’t offer practice questions or case studies. Users will still need a comprehensive understanding of the course material to succeed.
What This Document Provides
This review includes:
* Key vocabulary related to hematologic assessment (anemia, polycythemia, leukopenia, leukemia, erythropoiesis, hemolysis).
* Factors affecting blood glucose levels.
* An overview of the spleen, kidneys, liver, and lymph nodes in relation to hematologic health.
* Causes and symptoms of anemia, categorized by decreased production, blood loss, and increased destruction. A table referencing severe anemia symptoms is noted.
* Information on Erythrocyte Sedimentation Rate (ESR) as an indicator of inflammation.
* Details on Sickle Cell Disease, including treatment and nursing considerations, potential complications, and anticipated lab orders.
* An overview of Leukemia, including care of patients undergoing treatment, nursing considerations, treatment stages (induction, postinduction, maintenance), and anticipated lab/diagnostic orders.
* Information on Thrombocytopenia and Lymphoma, including types, chemotherapy treatments (ABVD, CHOP), and risk factors.
This preview does *not* include detailed treatment plans, dosage information, or comprehensive coverage of all hematologic disorders. It also does not include any practice questions or case studies.